Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ:VNDA
Vanda (VNDA) Stock Price & Analysis
318 Followers
VNDA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.75 - $11.90
Previous Close$6.11
Volume656.63K
Average Volume (3M)587.99K
Market Cap
$350.98M
Enterprise Value$152.52M
Total Cash (Recent Filing)$354.17M
Total Debt (Recent Filing)$155.71M
Price to Earnings (P/E)21.9
Beta0.61
Next Earnings
Aug 02, 2023EPS Estimate
-$0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.28
Shares Outstanding57,444,139
10 Day Avg. Volume493,612
30 Day Avg. Volume587,988
Standard Deviation0.14
R-Squared0.08
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.71
Price to Sales (P/S)5.62
Price to Cash Flow (P/CF)2.80
P/FCF Ratio2.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.59
Enterprise Value/Gross Profit0.60
Enterprise Value/Ebitda10.40
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Vanda News
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VNDA FAQ
What was Vanda Pharmaceuticals Inc.’s price range in the past 12 months?
Vanda Pharmaceuticals Inc. lowest stock price was $5.75 and its highest was $11.90 in the past 12 months.
What is Vanda Pharmaceuticals Inc.’s market cap?
Currently, no data Available
When is Vanda Pharmaceuticals Inc.’s upcoming earnings report date?
Vanda Pharmaceuticals Inc.’s upcoming earnings report date is Aug 02, 2023 which is in 66 days.
How were Vanda Pharmaceuticals Inc.’s earnings last quarter?
Vanda Pharmaceuticals Inc. released its earnings results on May 03, 2023. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of N/A by $0.06.
Is Vanda Pharmaceuticals Inc. overvalued?
According to Wall Street analysts Vanda Pharmaceuticals Inc.’s price is currently Overvalued.
Does Vanda Pharmaceuticals Inc. pay dividends?
Vanda Pharmaceuticals Inc. does not currently pay dividends.
What is Vanda Pharmaceuticals Inc.’s EPS estimate?
Vanda Pharmaceuticals Inc.’s EPS estimate is -$0.13.
How many shares outstanding does Vanda Pharmaceuticals Inc. have?
Vanda Pharmaceuticals Inc. has 57,444,138 shares outstanding.
What happened to Vanda Pharmaceuticals Inc.’s price movement after its last earnings report?
Vanda Pharmaceuticals Inc. reported an EPS of $0.06 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 7.512%.
Which hedge fund is a major shareholder of Vanda Pharmaceuticals Inc.?
Among the largest hedge funds holding Vanda Pharmaceuticals Inc.’s share is Hotchkis & Wiley Capital Management LLC. It holds Vanda Pharmaceuticals Inc.’s shares valued at 7M.
---
Vanda Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
VNDA Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 68.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $651.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.58%
12-Months-Change
Fundamentals
Return on Equity
3.07%
Trailing 12-Months
Asset Growth
6.79%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
---
Top 5 ETFs holding VNDA
Vanguard Health Care ETF
$1.19M
Fidelity MSCI Health Care Index ETF
$182.50K
iShares NASDAQ US Biotechnology UCITS ETF
$164.16K
Up to five ETFs with an Outperform Smart Score that hold VNDA. The ETFs are listed according to market value of VNDA within the ETF
---
---